April 4th 2025
The shift toward personalized medicines poses new challenges in cleanroom protocols.
January 31st 2025
Under this collaboration, GSK and Oxford will combine their complementary expertise in the immune system, vaccines, and cancer biology.
December 25th 2024
With the launch of its cobas mass spectrometry solution, Roche brings fully automated mass spec analysis to the clinical lab.
November 25th 2024
Fluorescence spectroscopy offers unique advantages for characterizing EVs.
September 5th 2024
Viral vectors and other complex biologic modalities require more specificity and higher sensitivity to detect and distinguish contaminants.